Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, today announced the publication of a ...
Modern chemistry is increasingly focused on developing sustainable processes that reduce energy consumption and minimize waste. Photocatalysis, which uses light to promote chemical reactions, offers a ...
Researchers at the Francis Crick Institute and Vividion Therapeutics have identified chemical compounds that can precisely ...
Novartis is serving up $60 million to partner with Matchpoint Therapeutics in hopes of getting an oral covalent inhibitor over the line for inflammatory diseases that have been historically difficult ...
Beta-blockers are widely prescribed pharmaceuticals used to manage cardiovascular conditions such as hypertension, ...